In addition, changes in the normal structure of mitochondria could lead to insulin resistance, which is an important pathophysiological process of NAFLD.[34,35] All the above studies have indicated that the SAMM50 gene and its expression products play a crucial role in the development of NAFLD. The gene discussed is SAMM50; the disease is metabolic dysfunction-associated steatotic liver disease.